Education
About Us
Working with TipRanks
Follow Us
Indoco Remedies Limited (IN:INDOCO)
:INDOCO
INDOCO Stock Chart & Stats
₹228.35
-₹0.55(-0.16%)
At close: 4:00 PM EST
₹228.35
-₹0.55(-0.16%)
Day’s Range― - ―
52-Week Range₹188.00 - ₹348.10
Previous CloseN/A
Volume47.33K
Average Volume (3M)38.33K
Market Cap
₹17.45B
Enterprise Value₹27.26B
Total Cash (Recent Filing)₹231.50M
Total Debt (Recent Filing)₹9.99B
Price to Earnings (P/E)―
Beta1.11
Next Earnings
May 26, 2026EPS Estimate
-3.8Next Dividend Ex-DateN/A
Dividend Yield0.08%
Share Statistics
EPS (TTM)-3.20
Shares Outstanding92,303,604
10 Day Avg. Volume7,145
30 Day Avg. Volume38,334
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.05
Price to Sales (P/S)1.26
P/FCF Ratio-6.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.18
Revenue Forecast (FY)₹17.72B
Bulls Say, Bears Say
Bulls Say
In‑house Manufacturing & R&DOwning manufacturing and R&D capabilities creates durable vertical integration: faster product development, greater quality control and regulatory compliance, and lower dependency on third-party suppliers. Over 2–6 months this supports sustained product launches and margin preservation.
Diversified Revenue Streams (Formulations, APIs, CDMO)Multiple business lines (finished formulations, APIs and contract manufacturing) reduce single-segment concentration and create cross‑cycle resilience. Structural diversification helps stabilize revenues when one channel faces pricing or regulatory headwinds over the medium term.
Domestic + Export Presence Across Multiple Dosage FormsA footprint spanning domestic and international markets and varied dosage forms broadens addressable markets and reduces dependence on any single market or therapy. This geographic and product breadth supports sustained revenue opportunities and mitigates localized disruptions.
Bears Say
Declining Revenue And Negative ProfitabilityRecent declines in revenue and a swing to negative net income signal structural pressures on demand, pricing or cost control. Persistently negative profitability undermines reinvestment capacity, weakens competitive positioning and can erode long‑term product development and market share.
Rising Financial LeverageHigher debt levels raise interest burden and reduce financial flexibility to fund capex, R&D or working capital. With profitability weak, elevated leverage increases refinancing and covenant risk and constrains strategic options over the medium term.
Negative Free Cash Flow And Weak Cash ConversionNegative free cash flow and deteriorating cash conversion indicate the business isn't generating sufficient internal cash to fund operations or investments. This pressures liquidity, may force external financing, and threatens sustained investment in growth and compliance.
Indoco Remedies Limited News
INDOCO FAQ
What was Indoco Remedies Limited’s price range in the past 12 months?
Indoco Remedies Limited lowest stock price was ₹188.00 and its highest was ₹348.10 in the past 12 months.
What is Indoco Remedies Limited’s market cap?
Indoco Remedies Limited’s market cap is ₹17.45B.
When is Indoco Remedies Limited’s upcoming earnings report date?
Indoco Remedies Limited’s upcoming earnings report date is May 26, 2026 which is in 66 days.
How were Indoco Remedies Limited’s earnings last quarter?
Indoco Remedies Limited released its earnings results on Feb 03, 2026. The company reported -₹3.2 earnings per share for the quarter, missing the consensus estimate of -₹2.55 by -₹0.65.
Is Indoco Remedies Limited overvalued?
According to Wall Street analysts Indoco Remedies Limited’s price is currently Overvalued.
Does Indoco Remedies Limited pay dividends?
Indoco Remedies Limited pays a Annually dividend of ₹0.2 which represents an annual dividend yield of 0.08%. See more information on Indoco Remedies Limited dividends here
What is Indoco Remedies Limited’s EPS estimate?
Indoco Remedies Limited’s EPS estimate is -3.8.
How many shares outstanding does Indoco Remedies Limited have?
Indoco Remedies Limited has 92,303,604 shares outstanding.
What happened to Indoco Remedies Limited’s price movement after its last earnings report?
Indoco Remedies Limited reported an EPS of -₹3.2 in its last earnings report, missing expectations of -₹2.55. Following the earnings report the stock price went up 11.011%.
Which hedge fund is a major shareholder of Indoco Remedies Limited?
Currently, no hedge funds are holding shares in IN:INDOCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Indoco Remedies Limited
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
Technical Analysis
Advanced Enzyme Technologies Ltd
―
Alembic Limited
―
Panacea Biotec Limited
―
SMS Pharmaceuticals Limited
―
Zota Health Care Ltd.
―